- 专利标题: Skin barrier composition
-
申请号: US17500604申请日: 2021-10-13
-
公开(公告)号: US11890294B2公开(公告)日: 2024-02-06
- 发明人: Kevin Hammond , Adrian Davis
- 申请人: HYPHENS PHARMA PTE. LTD.
- 申请人地址: SG Singapore
- 专利权人: HYPHENS PHARMA PTE. LTD.
- 当前专利权人: HYPHENS PHARMA PTE. LTD.
- 当前专利权人地址: SG Singapore
- 代理机构: BURNS & LEVINSON, LLP
- 代理商 Daniel W. Clarke
- 优先权: GB 07489 2017.05.10
- 分案原申请号: US16611529
- 主分类号: A61K31/7032
- IPC分类号: A61K31/7032 ; A61K9/00 ; A61K31/164 ; A61K31/191 ; A61K31/201 ; A61K31/365 ; A61K31/575 ; A61K33/30 ; A61K47/10 ; A61K47/14 ; A61K9/06
摘要:
The present invention provides a composition for topical administration of a polyhydroxy acid, such as lactobionate and especially zinc lactobionate, and low pH to an external body surface such as skin. The composition is designed to be highly effective in delivering low pH and zinc lactobionate across the layers of the skin to more effectively treat and prevent skin conditions involving a defective skin barrier such as eczema and severe dry skin.
公开/授权文献
- US20220031721A1 SKIN BARRIER COMPOSITION 公开/授权日:2022-02-03
信息查询
IPC分类: